Friday, June 3, 2011

Orexigen puts obesity drug development on hold

Shares of Orexigen tanked after they revealed they are halting work on FDA approval of their anti-obesity drug Contrave. 

http://finance.yahoo.com/news/Orexigen-puts-obesity-drug-apf-2428062223.html?x=0&.v=3

No comments:

Post a Comment